EyePoint 10-Q: Going-Concern Warning, $274.9M Nine-Month Loss, Sub-$1 Nasdaq Bid
EYPT is trading near its 52-week low of $0.31 (13% above the low).
Summary
EyePoint's Q3 10-Q discloses substantial doubt about its ability to continue as a going concern, a $274.9 million nine-month net loss, and roughly $10.1 million raised after quarter-end by selling 22,992,900 shares at about $0.44 — with the stock now below Nasdaq's $1.00 minimum bid.
Key Events · Earnings and Guidance · EYPT
-
Going-Concern Warning Disclosed
EyePoint states its $118.2 million in cash, cash equivalents and marketable securities at September 30, 2026 will not fund operations beyond one year from issuance, raising 'substantial doubt about the Company's ability to continue as a going concern.'
-
Nine-Month Loss Reaches $274.9M
Net loss was $274.9 million for the nine months ended September 30, 2026 versus $164.4 million a year earlier, with Q3 R&D up 71% to $81.7 million on DURAVYU Phase 3 spending. Operating cash burn was $229.7 million.
-
Post-Quarter ATM Sales at $0.44
After September 30, 2026 the company sold 22,992,900 shares under its Cantor ATM at a weighted average price of $0.44 for gross proceeds of approximately $10.1 million, far below the $8.49 Q3 average and $10.30 nine-month average.
-
Nasdaq Minimum Bid at Risk
The stock closed at $0.4041 on November 10, 2026, and last closed at or above $1.00 on October 16, 2026 — a close below $1.00 for more than 30 consecutive trading days would trigger a Nasdaq deficiency notice with a 180-day cure period.
Analysis · EYPT · Industrial Applications And Services
This morning's 8-K already flagged the quarter, but the 10-Q adds the two facts that change the thesis. First, management states plainly that cash of $118.2 million is not enough to fund operations beyond one year from issuance — 'substantial doubt about the Company's ability to continue as a going concern' — after burning $229.7 million of operating cash in nine months. Second, the company has been selling stock into a collapsing price: 22,992,900 shares after September 30 at a weighted average of $0.44 for about $10.1 million, versus $8.49 in Q3 and $10.30 for the nine months. With the stock at $0.4041 on November 10 and no close above $1.00 since October 16, a Nasdaq minimum-bid deficiency is now a live risk on top of a 53% workforce cut and the wind-down of the wet AMD program. The remaining value case rests almost entirely on the DME Phase 3 readout expected early in Q4 2027, which the current cash does not reach without new financing.
How filings like this one have moved
In the 30 days to Nov 12, 2026, 49.5% of the 210 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.54%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, EYPT was trading at $0.35 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $27.5M. The 52-week trading range was $0.31 to $19.11. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.